Substance / Medication

Sodium ascorbate

Overview

Active Ingredient
sodium ascorbate
RxNorm CUI
267366

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Maternal Common Cold or Fever During Pregnancy and the Risk of Orofacial Clefts in the Offspring: A Systematic Review and Meta-analysis.
Shi Fang-Ping, Huang Ying-Ying, Dai Qiao-Qun et al. · Cleft Palate Craniofac J · 2023
PMID: 34918551Meta-Analysis
Acquired methemoglobinemia: A systematic review of reported cases.
Gao Haijuan, Basri Rabia, Tran Minh-Ha · Transfus Apher Sci · 2022
PMID: 34740513Meta-Analysis
2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death.
Grundlingh Johann, Dargan Paul I, El-Zanfaly Marwa et al. · J Med Toxicol · 2011
PMID: 21739343Meta-AnalysisFull text (PMC)
Methemoglobinemia: a systematic review of the pathophysiology, detection, and treatment.
Ashurst John, Wasson Megan · Del Med J · 2011
PMID: 21954509Meta-Analysis
Methemoglobinemia related to local anesthetics: a summary of 242 episodes.
Guay Joanne · Anesth Analg · 2009
PMID: 19224791Meta-Analysis
Mega-dose sodium ascorbate: a pilot, single-dose, physiological effect, double-blind, randomized, controlled trial.
Yanase Fumitaka, Spano Sofia, Maeda Akinori et al. · Crit Care · 2023
PMID: 37828547RCTFull text (PMC)
Methemoglobinemia in patients undergoing esophagogastroduodenoscopy: a randomized controlled trial.
Hall Noah M, Jones Frances J, Ainsworth Craig R et al. · Mil Med · 2013
PMID: 23756080RCT
Methemoglobin levels in generally anesthetized pediatric dental patients receiving prilocaine versus lidocaine.
Gutenberg Lauren L, Chen Jung-Wei, Trapp Larry · Anesth Prog · 2013
PMID: 24010987RCTFull text (PMC)
Effects of time and concentration of sodium ascorbate on reversal of NaOCl-induced reduction in bond strengths.
Weston Charles H, Ito Shuichi, Wadgaonkar Bakul et al. · J Endod · 2007
PMID: 17804335RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Sodium ascorbate (substance)
SNOMED CT
126231003
UMLS CUI
C0887557
RxNorm CUI
267366

Clinical Data

This intervention maps to 12 entities in the Ltrl knowledge graph.

5
Conditions
3
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Sodium ascorbate: Uses, Evidence & Side Effects | Ltrl